- Home
- TDAY vs ORIC Comparison
TDAY vs ORIC Comparison
Compare TDAY & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.36
HOLD
Current Price
$8.37
Company Overview
Basic Information| Metric | TDAY | ORIC |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 675.2M | 783.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TDAY | ORIC |
|---|---|---|
| Price | $5.36 | $8.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $19.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $2,338,505,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.55 | $3.90 |
| 52 Week High | $5.80 | $14.93 |
Technical Indicators
Market Signals| Indicator | TDAY | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 29.01 |
| Support Level | N/A | $7.98 |
| Resistance Level | N/A | $8.61 |
| Average True Range (ATR) | 0.00 | 0.64 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 0.00 | 10.06 |
Price Performance
Historical Comparison TDAY
ORIC
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.